These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 37210571)

  • 81. LAUDES Study: impact of digital ulcers on hand functional limitation, work productivity and daily activities, in systemic sclerosis patients.
    Castellví I; Eguiluz S; Escudero-Contreras A; Ríos JJ; Calvo-Alén J; Callejas-Rubio JL; De la Puente C; Simeón CP; Narváez FJ; Espinosa G; Carreira PE; Rubio-Rivas M; Alegre JJ; Guillén-Del-Castillo A; Román-Ivorra JA; Fonollosa V;
    Rheumatol Int; 2019 Nov; 39(11):1875-1882. PubMed ID: 31522232
    [TBL] [Abstract][Full Text] [Related]  

  • 82. The correlation between durometer score and modified Rodnan skin score in systemic sclerosis.
    Moon KW; Song R; Kim JH; Lee EY; Lee EB; Song YW
    Rheumatol Int; 2012 Aug; 32(8):2465-70. PubMed ID: 21769489
    [TBL] [Abstract][Full Text] [Related]  

  • 83. Reliability and validity of the Italian version of the hand functional disability scale in patients with systemic sclerosis.
    Ingegnoli F; Galbiati V; Boracchi P; Comi D; Gualtierotti R; Zeni S; Fantini F
    Clin Rheumatol; 2008 Jun; 27(6):743-9. PubMed ID: 18040599
    [TBL] [Abstract][Full Text] [Related]  

  • 84. Effect of gastrointestinal manifestations on quality of life in 87 consecutive patients with systemic sclerosis.
    Omair MA; Lee P
    J Rheumatol; 2012 May; 39(5):992-6. PubMed ID: 22467930
    [TBL] [Abstract][Full Text] [Related]  

  • 85. Skin sclerosis is only of limited value to identify SSc patients with severe manifestations--an analysis of a distinct patient subgroup of the German Systemic Sclerosis Network (DNSS) Register.
    Hanitsch LG; Burmester GR; Witt C; Hunzelmann N; Genth E; Krieg T; Lehmacher W; Melchers I; Meurer M; Müller-Ladner U; Schulze-Lohoff E; Becker M; Sunderkoetter C; ; Riemekasten G
    Rheumatology (Oxford); 2009 Jan; 48(1):70-3. PubMed ID: 19056798
    [TBL] [Abstract][Full Text] [Related]  

  • 86. Disease progression in systemic sclerosis-overlap syndrome is significantly different from limited and diffuse cutaneous systemic sclerosis.
    Moinzadeh P; Aberer E; Ahmadi-Simab K; Blank N; Distler JH; Fierlbeck G; Genth E; Guenther C; Hein R; Henes J; Herich L; Herrgott I; Koetter I; Kreuter A; Krieg T; Kuhr K; Lorenz HM; Meier F; Melchers I; Mensing H; Mueller-Ladner U; Pfeiffer C; Riemekasten G; Sárdy M; Schmalzing M; Sunderkoetter C; Susok L; Tarner IH; Vaith P; Worm M; Wozel G; Zeidler G; Hunzelmann N;
    Ann Rheum Dis; 2015 Apr; 74(4):730-7. PubMed ID: 24389298
    [TBL] [Abstract][Full Text] [Related]  

  • 87. Clinical Characteristics and Factors Associated With Disability and Impaired Quality of Life in Children With Juvenile Systemic Sclerosis: Results From the Childhood Arthritis and Rheumatology Research Alliance Legacy Registry.
    Stevens BE; Torok KS; Li SC; Hershey N; Curran M; Higgins GC; Moore KF; Egla Rabinovich C; Dodson S; Stevens AM;
    Arthritis Care Res (Hoboken); 2018 Dec; 70(12):1806-1813. PubMed ID: 29457372
    [TBL] [Abstract][Full Text] [Related]  

  • 88. Controlling the digital ulcerative disease in systemic sclerosis is associated with improved hand function.
    Mouthon L; Carpentier PH; Lok C; Clerson P; Gressin V; Hachulla E; Bérezné A; Diot E; Van Kien AK; Jego P; Agard C; Duval-Modeste AB; Sparsa A; Puzenat E; Richard MA;
    Semin Arthritis Rheum; 2017 Jun; 46(6):759-766. PubMed ID: 28214014
    [TBL] [Abstract][Full Text] [Related]  

  • 89. The symptom burden index: development and initial findings from use with patients with systemic sclerosis.
    Kallen MA; Mayes MD; Kriseman YL; de Achaval SB; Cox VL; Suarez-Almazor ME
    J Rheumatol; 2010 Aug; 37(8):1692-8. PubMed ID: 20516027
    [TBL] [Abstract][Full Text] [Related]  

  • 90. The Italian version of the Hand Mobility in Scleroderma (HAMIS) test: evidence for its validity and reliability.
    Del Rosso A; Maddali-Bongi S; Sigismondi F; Miniati I; Bandinelli F; Matucci-Cerinic M
    Clin Exp Rheumatol; 2010; 28(5 Suppl 62):S42-7. PubMed ID: 21050544
    [TBL] [Abstract][Full Text] [Related]  

  • 91. Lack of specificity of the 6-minute walk test as an outcome measure for patients with systemic sclerosis.
    Schoindre Y; Meune C; Dinh-Xuan AT; Avouac J; Kahan A; Allanore Y
    J Rheumatol; 2009 Jul; 36(7):1481-5. PubMed ID: 19487260
    [TBL] [Abstract][Full Text] [Related]  

  • 92. Predictors of disease worsening defined by progression of organ damage in diffuse systemic sclerosis: a European Scleroderma Trials and Research (EUSTAR) analysis.
    Becker M; Graf N; Sauter R; Allanore Y; Curram J; Denton CP; Khanna D; Matucci-Cerinic M; de Oliveira Pena J; Pope JE; Distler O; ;
    Ann Rheum Dis; 2019 Sep; 78(9):1242-1248. PubMed ID: 31227488
    [TBL] [Abstract][Full Text] [Related]  

  • 93. Comparison of pulmonary function, respiratory symptoms, functional level, and health-related quality of life in patients with systemic sclerosis according to smoking status.
    Yakut H; Ozalevli S; Aktan R; Erez Y; Birlik M
    Physiother Theory Pract; 2024 May; 40(5):919-928. PubMed ID: 36350737
    [TBL] [Abstract][Full Text] [Related]  

  • 94. Clinical trajectories of hand function impairment in systemic sclerosis: an unmet clinical need across disease subsets.
    De Lorenzis E; Kakkar V; Di Donato S; Wilson M; Barnes T; Denton C; Derrett-Smith E; Douglas K; Helliwell P; Herrick AL; Saleem B; Nisar M; Morley C; Green L; Alcacer-Pitarch B; Del Galdo F
    RMD Open; 2024 Jan; 10(1):. PubMed ID: 38216288
    [TBL] [Abstract][Full Text] [Related]  

  • 95. Determinants of disability, quality of life and depression in dermatological patients with systemic scleroderma.
    Müller H; Rehberger P; Günther C; Schmitt J
    Br J Dermatol; 2012 Feb; 166(2):343-53. PubMed ID: 21916888
    [TBL] [Abstract][Full Text] [Related]  

  • 96. Health-related quality of life in systemic sclerosis as measured by the Short Form 36: relationship with clinical and biologic markers.
    Del Rosso A; Boldrini M; D'Agostino D; Placidi GP; Scarpato A; Pignone A; Generini S; Konttinen Y; Zoppi M; Vlak T; Placidi G; Matucci-Cerinic M
    Arthritis Rheum; 2004 Jun; 51(3):475-81. PubMed ID: 15188336
    [TBL] [Abstract][Full Text] [Related]  

  • 97. The Canadian systemic sclerosis oral health study II: the relationship between oral and global health-related quality of life in systemic sclerosis.
    Baron M; Hudson M; Tatibouet S; Steele R; Lo E; Gravel S; Gyger G; El Sayegh T; Pope J; Fontaine A; Masetto A; Matthews D; Sutton E; Thie N; Jones N; Copete M; Kolbinson D; Markland J; Nogueira-Filho G; Robinson D; Gornitsky M
    Rheumatology (Oxford); 2015 Apr; 54(4):692-6. PubMed ID: 25288781
    [TBL] [Abstract][Full Text] [Related]  

  • 98. Association between core stability and physical function, functional performance in patients with systemic sclerosis.
    Yakut H; Özalevli S; Birlik AM
    Int J Rheum Dis; 2021 Apr; 24(4):548-554. PubMed ID: 33463900
    [TBL] [Abstract][Full Text] [Related]  

  • 99. Impact of pain in health related quality of life of patients with systemic sclerosis.
    Georges C; Chassany O; Toledano C; Mouthon L; Tiev K; Meyer O; Ilie D; Rambeloarisoa J; Marjanovic Z; Cabane J; Sereni D; Pouchot J; Farge D
    Rheumatology (Oxford); 2006 Oct; 45(10):1298-302. PubMed ID: 16754629
    [TBL] [Abstract][Full Text] [Related]  

  • 100. The Disability Index of the Health Assessment Questionnaire is a predictor and correlate of outcome in the high-dose versus low-dose penicillamine in systemic sclerosis trial.
    Clements PJ; Wong WK; Hurwitz EL; Furst DE; Mayes M; White B; Wigley F; Weisman M; Barr W; Moreland L; Medsger TA; Steen V; Martin RW; Collier D; Weinstein A; Lally E; Varga J; Weiner SR; Andrews B; Abeles M; Seibold JR
    Arthritis Rheum; 2001 Mar; 44(3):653-61. PubMed ID: 11263780
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.